EU research on rare diseases

In the European Union, a rare disease is one that affects no more than 1 person in 2,000.  Between 6,000 and 8,000 different rare diseases affect an estimated 30 million people in the EU.

The area of rare diseases has been long recognised as a field where EU and international collaboration is an indispensable condition to progress. 

The EU has supported the field extensively through its research and innovation framework programmes, with more than €1.8 billion made available over the past 14 years under the Seventh Framework Programme (FP7) and Horizon 2020, to more than 320 projects on interdisciplinary research in the area of rare diseases.

These projects span across all medical areas i.e. neurological, immunological, metabolic diseases or rare cancers, and contribute to the understanding of the causes and characteristics of rare diseases, to develop new diagnostics and therapies for patients and to promote best practices for use in hospitals and healthcare systems.

Such collaborations allow researchers, clinicians, companies (including SMEs) and patient organisations to pool resources, data and complementary expertise, which no individual country could achieve alone.

Horizon Europe (2021-2027), the new research and innovation funding programme, will continue to support these efforts. Notably, a proposed European Partnership on rare diseases is expected to catalyse a systemic transformation in the area, with the goal of improving the quality of life for people living with a rare disease.

In addition to EU-funded collaborative projects, specific initiatives offer a solid framework for enhanced cooperation in the area.

European Joint Programme on Rare Diseases

The EU has supported the coordination between research funders across Europe and beyond. The launch in January 2019 of the European Joint Programme on Rare Diseases (EJP RD) marked an important milestone in Europe.

EJP RD is creating a comprehensive, sustainable ecosystem allowing a virtuous circle between research, care and medical innovation. EJP RD pools resources at national and European level at a scale never achieved before.

It gathers research funders, universities, research organisations and infrastructures, hospitals and patient organisations from more than 135 institutions in 35 countries, including 26 out of 27 EU countries.

The EU contributes €55 million out of a total investment of over €100 million. Importantly, EJP RD involves the 24 European Reference Networks, representing around 400 hospitals that provide highly specialised care across Europe on complex or rare diseases and conditions.

European Rare disease research Coordination and support Action Consortium (ERICA)

A new consortium, the European Rare disease research Coordination and support Action(ERICA) is starting its work in March 2021, with the aim to coordinate the clinical research activities of the European Reference Networks  (ERNs).

ERICA unites the expertise of the 24 ERNs and will create a collaborative platform to share knowledge and good practices through the assembly of transdisciplinary research groups across the different medical areas.

International Rare Diseases Research Consortium (IRDiRC)

The European Commission has been actively driving the international research collaboration and coordination in the field. 

The International Rare Diseases Research Consortium (IRDiRC) was established in 2011 by the European Commission and the US National Institutes of Health  to foster and coordinate international efforts with the ultimate goal to accelerate medical breakthroughs for people affected by rare diseases.

Related links

EU rare diseases research (Factsheet)

Showcasing development of therapies for rare diseases (Factsheet)

Rare diseases - a major unmet medical need infographic, report, leaflet

World Rare Diseases Day

European Reference Networks

Funding opportunities

  • Horizon Europe

    Funding for health under the research and innovation framework programme, Horizon Europe. .

Collaboration and jobs

Projects and results

  • EU-funded projects (CORDIS)

    Projects in the area of rare diseases on the Commission's primary portal for results of EU-funded research projects.

  • Project success stories

    Stories of particularly successful EU-funded research projects.

  • Horizon Results Platform

    Platform where framework programme funding recipients present their results to search, contact their owners and form partnerships.

Scientific publications, tools and databases

  • Horizon 2020 dashboard

    Interactive reporting platform composed of a set of sheets that allows series of views to discover and filter Horizon 2020 data.

  • Scientific publications

    Scientific publications produced by the European Commission (JRC).

  • EU Open Data Portal

    Single point of access to open data produced by the EU institutions. All data free to use for commercial and non-commercial purposes.

  • OpenAIRE

    You can access all scientific publications from Horizon 2020 via OpenAIRE.

Latest

Contact

  • Research enquiry service

    You can contact the research enquiry service to find out more about research in Europe, the EU's research and innovation funding programmes as well as calls for proposals and project funding.  

  • National contact points

    The national contact points (NCP) network gives guidance and information on participating in Horizon 2020. NCPs are established in all EU countries and many non-EU countries.

  • European IP Helpdesk

    Service that offers an intellectual property rights helpline, training and online library.

  • Enterprise Europe Network

    The Enterprise Europe Network is the world’s largest support network for small and medium-sized enterprises (SMEs) with international ambitions. 

Related Commission departments